CXCL16 enhances IFNγ production by NKT cells, while IL-12 enhances IFNγ secretion by iNKT cells, NK cells, Th1 CD4+ and CD8+ T cells, providing a positive feedback loop to support a robust anti-tumor immune response [70]. The gene discussed is CD8A; the disease is neoplasm.